Microfluidics Market Size, Share, Competitive Landscape and Trend Analysis Report by APPLICATION, by Material and by COMPONENT : Global Opportunity Analysis and Industry Forecast, 2023-2032

The microfluidics market provides practical application of small fluid volumes for design of systems and development of solutions. The global healthcare technology market is estimated to reach $53 billion by 2014 at a CAGR of 16%. Microfluidics is an emerging technology with growing acceptability in healthcare applications. The key driver for the microfluidics market is the –great (or rising) demand in point-of-care (POC) and in-vitro diagnostics. For example, according to World Health Organization (WHO), 95 million people received HIV testing in low and middle-income countries in 2010. Application of microfluidics in HIV testing at POCs is expected to cut cost, thereby increase the demand for the technology.

However, several regulatory standards are being made for the implementation of microfluidics in healthcare. The regulatory standards consume too much time for the approval process of microfluidics devices. Another challenge for the growth of the market is the implementation of emerging microfluidics technology in existing applications. To overcome this challenge, companies are investing in research and development.    

Key companies profiled in this report are Abbott Laboratories, Inc., Perkinelmer, Inc., Cepheid, Inc., Raindance Technologies, Becton, Dickinson, Bio-Rad Laboratories, Inc., Johnson & Johnson, Life Technologies Corporation, Microfluidic Chipshop GMBH and Siemens Healthcare.

KEY BENEFITS

• This report provides market intelligence with respect to technology, components and geographies
• Deep dive analysis of top factors impacting the market growth
• Value chain analysis, Porter’s five forces, top investment pockets are analyzed and presented in detail in the report
• SWOT analysis and strategic developments are included in the report for key players so that companies can understand the competitive landscape and make alterations in their plans
• Examine the challenges and opportunities in the microfluidics market so that companies can capitalize in the opportunities and increase revenue
• Estimations are derived from the current market scenario and expected future trends chalked out  for the period as historic figures
• To analyze the key strategies adopted by major market players engaged in the market
• Geographic analysis offers in-depth implications of the trends in various regions; therefore, companies can make region specific strategies to gain competitive advantages
• The report provides impact analysis of the drivers, restraints and opportunities for short and mid-term

KEY AUDIENCES

• Companies dealing in Microfluidics
• Venture capitalists and investors interested in this market
• Research organizations

  Microfluidics Market Report Highlights

Aspects	Details
By APPLICATION	IN-VITRO DIAGNOSTICS Clinical Diagnostics Point-of-Care (POC) PHARMACEUTICAL & LABORATORY ANALYTICS Cell-Based Assays Genomic Analysis Proteomic Analysis Capillary Electrophoresis Microdispensing Microreaction LABORATORY TESTING Food & Agriculture Testing Environmental Testing Others DRUG DELIVERY
By Material	POLYMER GLASS SILICON OTHERS
By COMPONENT	MICROFLUIDIC CHIPS MICROFLUIDIC SENSORS OTHERS
By Region	North America  (U.S, Canada, Mexico) Europe  (Germany, France, Uk, Italy, Spain, Rest of Europe) Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	ILLUMINA, INC., THERMO FISHER SCIENTIFIC INC., PERKINELMER INC., FLUIDIGM CORPORATION, QIAGEN N.V., LONZA GROUP, MICRONIT MICROTECHNOLOGIES B.V., DOLOMITE MICROFLUIDICS, ELVEFLOW, BIORAD LABORATORIES, INC.